Thrive Capital Management (Pennsylvania)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,595
| Closed | -$228K | – | 185 |
|
|
2024
Q2 | $228K | Buy |
+1,595
| New | +$228K | 0.1% | 169 |
|
|
2024
Q1 | – | Sell |
-4,223
| Closed | -$437K | – | 181 |
|
|
2023
Q4 | $437K | Buy |
4,223
+544
| +15% | +$56.3K | 0.23% | 72 |
|
|
2023
Q3 | $335K | Buy |
3,679
+409
| +13% | +$37.2K | 0.19% | 86 |
|
|
2023
Q2 | $265K | Buy |
+3,270
| New | +$265K | 0.15% | 104 |
|